Oct 12, 2022 All four of these drugmakers are expecting important FDA approval decisions over the next few months. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.
Following the earnings report the stock price went down -0.386%. The company reported $4.77 https://dotbig.com/markets/stocks/BIIB/ earnings per share for the quarter, beating the consensus estimate of $4.126 by $0.644.
Get the InvestorsObserver App
Providing investment advice to tens of thousands of investors for more than three decades, he has earned a reputation as a savvy stock picker and unrivaled portfolio manager. The market capitalization https://dotbig.com/ sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.
- Following the earnings report the stock price went down -0.386%.
- Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.
- Now, it seems that practically everyone has forgotten about the lawsuit settlement and jumped on the Biogen bandwagon.
- Traders and their algorithms have baked all of the current and anticipated positive news into the proverbial pie.
- Gurus may be added or dropped from the GuruFocus site at any time.
- Biogen is an American biotech company based in Cambridge, Massachusetts.
Fundamental company data provided by Morningstar, updated daily. It is focused on discovering, developing and delivering therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. It has a portfolio of medicines to treat multiple sclerosis , spinal muscular atrophy and Alzheimer’s disease.
BIIB Biogen Inc.Stock Price & Overview
If a user or application submits more than 10 requests per second, further requests from the IP address may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not Forex news intended or expected to impact individuals browsing the SEC.gov website. The settlement will be spread over 13 years in a mix of cash and drugs, with about $100 million earmarked for Native American Tribes. The company’s generic version of overdose medication Narcan is also part of the deal, at 20% of the $1.2 billion wholesale acquisition cost.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that Biogen Inc stock integrity intact, from our research and data to our policies on content and your personal data. Undervalued high-quality stocks may be just the ticket in a choppy market.
Stock price history for Biogen (BIIB)
As Piper Sandler analyst Christopher Raymond put it, the clinical meaningfulness of the lecanemab results “is still TBD.” Yet, even though the ultimate outcome is to be determined, traders have priced in the best-case Biogen Inc stock price today scenario for Biogen. The very next day, financial traders all but forgot about this legal settlement. That’s because Biogen and Eisai announced the results of a clinical trial for lecanemab on Sept. 27.
Why Is BioMarin (BMRN) Up 14.1% Since Last Earnings Report?
For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Biogen Inc.. As the market stays in correction https://dotbig.com/ territory, high-quality undervalued stocks including Biogen and Salesforce look poised to gain. Here are our analysts’ top stock ideas in each sector for the quarter. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services.
Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and mo… Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.
BIIB FAQ
Oct 26, 2022 There’s a much bigger story for this biotech than its improved 2022 outlook.3 Alzheimer’s Therapy Stocks to Invest in Jim Halley
These funds had the largest holdings of the drugmaker’s stock before it soared. These wide- and narrow-moat stocks have suffered losses lately and are now trading in 4- and 5-star range. U.S. ETFs collected modest inflows as stocks and bonds sold off last month. Growth stocks were down in the quarter yet still managed to outperform dotbig value stocks. Teva Pharmaceutical Industries Ltd. on Monday said its current CEO Kåre Schultz will retire on Dec. 31. Robert Francis, former CEO of Sandoz and an executive at Novartis AG and former executive at Biogen Inc. , will beco… The stock’s overall A rating indicates a Strong Buy in our proprietary rating system.